Company intelligence / Profile preview

Akampion

Hamburg, Hamburg, Germany

Ownership: Private
Development stage: Other

Overview

Akampion is not a drug developer; it provides corporate communications, strategy, and investor relations services to life sciences, biotech, pharmaceutical, and medical technology companies, leveraging deep sector expertise and extensive industry networks[1][3].

Industry: Consulting

Partnerships

Works with leading European biotech, pharma companies, academic institutions, and investors as clients (examples: supporting MetrioPharm, Mabylon, Ebenbuild, Inverna Therapeutics)

Beyond the preview

Go deeper on Akampion.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Akampion.

Explore the full profile